I keep coming back to Trevor Scott's comment at the 2023 AGM - that his work with Neuren would be done in 12 months.
Because he didn't elaborate further, we can only guess what he meant - but I took it to mean that he expected the Board would then be in a position to consider a serious t/o offer.
Given the Pitt Hopkins trial results are due to lob around his stated time-frame, one could further surmise that the Board had decided to await this result in the belief that it would replicate those from the PMS phase 2 trial.
I keep coming back to Trevor Scott's comment at the 2023 AGM -...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$23.97 |
Change
3.260(15.7%) |
Mkt cap ! $3.060B | |||
| Open | High | Low | Value | Volume |
| $23.00 | $24.00 | $21.60 | $27.11M | 1.181M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 942 | $23.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $23.97 | 27 | 1 |
View Market Depth
| Last trade - 16.10pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$24.00 |
Change
3.260 ( 16.0 %) |
||||
| Open | High | Low | Volume | ||
| $22.98 | $24.00 | $21.60 | 310545 | ||
| Last updated 15.59pm 27/05/2024 ? | |||||
| NEU (ASX) Chart |